Skip to content
Lower risk Drug recall · FDA · Published July 30, 2021

BayCare Central Pharmacy: Sterile IV Syringes Recalled Due to Lack of Sterility Assurance

BayCare Central Pharmacy recalls 100 mg/5 mL succinylcholine chloride syringes due to lack of sterility assurance. This could lead to infections if used improperly. Affected lots: SUCC10020210624 (expiring 09/22/2021).

🇺🇸 FDA recall #D-0702-2021DrugBayCare Central Pharmacy ›
Take action

Contact the company

Recalling firmBayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy7802 E Telecom Pkwy · Temple Terrace, FL 33637-0928
✎ GovInfoNow plain-language explainer

What happened, in plain English

BayCare Central Pharmacy has recalled certain IV syringes for succinylcholine chloride due to a lack of sterility assurance. This means the syringes could cause infections if used in medical procedures. Patients should not use these syringes and contact their healthcare provider for alternatives. Read more at govinfonow.com/recall/35996-baycare-central-pharmacy-sterile-iv-syringes-recalled-due-to-lack.

Source Summary by GovInfoNow · govinfonow.com/recall/35996-baycare-central-pharmacy-sterile-iv-syringes-recalled-due-to-lack · Updated August 18, 2026 · FDA enforcement record: FDA #D-0702-2021

Cite this page

“BayCare Central Pharmacy: Sterile IV Syringes Recalled Due to Lack of Sterility Assurance.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35996-baycare-central-pharmacy-sterile-iv-syringes-recalled-due-to-lack. Based on FDA recall #D-0702-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0702-2021%22&limit=1).

Why it’s dangerous

The syringes lack proper sterility assurance, meaning they could be contaminated with bacteria or other pathogens. If used in medical procedures, this could lead to infections in patients. The risk is primarily for individuals receiving IV treatments with these syringes.

Who’s affected

Patients receiving IV treatments with the recalled succinylcholine chloride syringes are affected. Healthcare providers using these syringes for medical procedures are at risk of infection.

How to tell if you have this one

Check for the lot number SUCC10020210624 on the syringe packaging. The syringes are labeled as 100 mg/5 mL succinylcholine chloride for IV use only.

  • Brand
    BayCare Central Pharmacy
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Syringes

    Discard the recalled syringes immediately if you have them.

Where it went and when

Where it was distributed

Distributed in Florida.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: yesFL

FDA distribution: “FL” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Florida.

Recall timeline

FDA terminated this recall 3 months after the firm started it.

1. Firm started the recall: Jul 30, 202112. FDA classified it Class II: Aug 4, 202123. Published in FDA’s Enforcement Report: Aug 11, 202134. FDA terminated the recall: Oct 22, 202142021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0702-2021 (July 30, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0702-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA